WELLMIND VERTIGO- semecarpus anacardium juice, anamirta cocculus seed, conium maculatum flowering top, kerosene, and selenium tablet 
MediNatura Inc.

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

WellMind Vertigo RX Tablet

DESCRIPTION

Each 300 mg tablet contains:

Active Ingredients:

Ingredient name               Potency        Quantity    Final dilution

Anacardium orientale        6X                 10 mg        7.5X

Cocculus indicus               4X                 210 mg      4.15X

Conium maculatum           3X                 30 mg       4X

Petroleum                        8X                 20 mg       9.2X

Selenium metallicum        6X                 10 mg       7.5X

Selenium metallicum        12X               10 mg      13.5X

Selenium metallicum       30X                10 mg      31.5X

INDICATIONS & USAGE

WellMindTM Vertigo Tablets are a homeopathic drug product indicated for the treatment of vertigo/dizziness ofvarious origins; mild cognitive impairment (MCI) such as lack of concentration and forgetfulness.

DOSAGE AND ADMINISTRATION

General Considerations

• The dosage schedules listed below can be used as a general guide for the administration of WellMindTM Vertigo Tablets.

• Allow tablets to dissolve completely in the mouth, do not swallow.

Standard Dosage: Adults and children 12 years and older:

3 tablets per day, taking 1 tablet every 4 to 6 hours.

Acute Dosage:Adults and children 12 years and older:

1 tablet every ½ to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.

CONTRAINDICATIONS

• WellMindTM Vertigo Tablets are contraindicated in patients with known hypersensitivity to WellMindTM Vertigo or any of its ingredients.

Do not use during pregnancy or breastfeeding.

WARNINGS

None

ADVERSE REACTIONS

Post-marketing Experience

• No adverse events with a causal relationship to WellMindTM Vertigo tablets have been reported.

OVERDOSAGE

No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions.

CLINICAL PHARMACOLOGY

Mechanism of Action

The exact mechanism of WellMindTM Vertigo Tablets is not fully understood.

Pharmacodynamics

Not applicable for homeopathic medicinal products.

DOSAGE & ADMINISTRATION

300 mg tablets each containing the active ingredients in the strengths listed under Description.

WellMind Vertigo RX Tablet.jpg

WELLMIND VERTIGO 
semecarpus anacardium juice, anamirta cocculus seed, conium maculatum flowering top, kerosene, and selenium tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:50114-9001
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SEMECARPUS ANACARDIUM JUICE (UNII: Y0F0BU8RDU) (SEMECARPUS ANACARDIUM JUICE - UNII:Y0F0BU8RDU) SEMECARPUS ANACARDIUM JUICE6 [hp_X]
ANAMIRTA COCCULUS SEED (UNII: 810258W28U) (ANAMIRTA COCCULUS SEED - UNII:810258W28U) ANAMIRTA COCCULUS SEED4 [hp_X]
CONIUM MACULATUM FLOWERING TOP (UNII: Q28R5GF371) (CONIUM MACULATUM FLOWERING TOP - UNII:Q28R5GF371) CONIUM MACULATUM FLOWERING TOP3 [hp_X]
PETROLEUM ALKYLATE (UNII: Y61895R84U) (PETROLEUM ALKYLATE - UNII:Y61895R84U) PETROLEUM ALKYLATE8 [hp_X]
SELENIUM (UNII: H6241UJ22B) (SELENIUM - UNII:H6241UJ22B) SELENIUM6 [hp_X]
Inactive Ingredients
Ingredient NameStrength
LACTOSE (UNII: J2B2A4N98G)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize9mm
FlavorImprint Code Mountain
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:50114-9001-21 in 1 CARTON01/01/201508/31/2024
1100 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic01/01/201508/31/2024
Labeler - MediNatura Inc. (102783016)
Establishment
NameAddressID/FEIBusiness Operations
MediNatura Inc.102783016manufacture(50114-9001)

Revised: 10/2021
Document Id: 9429158c-c8cc-48c2-9ef8-d1e444c31787
Set id: b37d42a4-1e54-4dab-a437-ea307c4b5400
Version: 4
Effective Time: 20211018
 
MediNatura Inc.